OPS
ITRM

Orion Portfolio Solutions’s Iterum Therapeutics ITRM Stock Holding History

Orion Portfolio Solutions’s Portfolio ITRM Stock Details ITRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-123
Closed -$5K – 2321
2020
Q1 		$5K Buy
+123
New +$5.17K ﹤0.01% 1298

Other funds holding ITRM

CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ML
McAdam LLC Philadelphia, Pennsylvania $2.59B AUM 21.24% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $120M AUM 63.01% 1-Year Est. Return

Orion Portfolio Solutions's ITRM Position: Q2 2020 in Review

Orion Portfolio Solutions sold out of Iterum Therapeutics (ITRM) in Q2 2020, closing a stake of 123 shares — an estimated $5K sold.

Orion Portfolio Solutions first reported a position in ITRM in Q1 2020 and held it in 1 quarter. The position peaked at $5K in Q1 2020. 10 funds tracked by Wall St. Rank hold ITRM as of Q2 2020.

  • Orion Portfolio Solutions reported no remaining Iterum Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Orion Portfolio Solutions sold 123 Iterum Therapeutics shares in Q2 2020, an estimated $5K.
  • Orion Portfolio Solutions first reported a position in Iterum Therapeutics in Q1 2020 and held it in 1 quarter.
  • Orion Portfolio Solutions's Iterum Therapeutics position peaked at $5K in Q1 2020.
  • 10 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q2 2020.

Based on Orion Portfolio Solutions's 13F filing for Q2 2020, filed 13 Aug 2020.